Molecular and immunohistochemistry markers that are currently used to diagnose MF are usually negative markers, such as loss of expression of, for example, CD7 or CD26, but this kind of aberrant surface expression shows considerable variability from case to case48. The gene discussed is DPP4; the disease is mycosis fungoides.